Key Takeaways Chronic, low-grade inflammation and insulin resistance drive each other in a two-way loop that starts largely in visceral fat. Mesenchymal stem cells are being studied for their ability to calm this inflammation and support insulin sensitivity, not to replace diet, exercise, or medication. A 2022 randomized trial found
Quick Summary In 2026, stem cell therapy for diabetes shows measurable improvement in 60-80% of patients, including better blood sugar control, reduced insulin use, and improved insulin resistance. Type 2 diabetes patients often respond better than type 1. However, full remission remains uncommon, and results depend on disease duration, treatment
Quick Read Summary Stem Cell Therapy For Diabetes Type 2: Can It Help Blood Sugar Control? Stem cell therapy is being studied as a potential way to improve insulin production and support blood sugar control in diabetes type 2. Early clinical trial results show some patients had lower blood sugar
